ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.82
      0.10%
      US Tech 100
      19,853.60
      0.04%
      Dow Jones
      39,446.90
      0.18%
      Brent Oil
      85.985
      -0.60%
      Bitcoin
      56,415.53
      1.02%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. BioPharmX Corporation (BPMX)

      7. BioPharmX Corporation (BPMX) News

      BPMX

      BioPharmX (BPMX)

      BioPharmX Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:BPMX
      DateTimeSourceHeadlineSymbolCompany
      01/29/201911:49AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
      12/20/20184:42PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      12/20/20184:30PMPR Newswire (US)BioPharmX Receives Notice of Noncompliance from NYSE AmericanAMEX:BPMXBioPharmX Corporation
      12/07/20184:10PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
      12/07/20183:09PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
      12/06/20184:20PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      12/06/20184:10PMPR Newswire (US)BioPharmX Reports Third Quarter 2019 Financial ResultsAMEX:BPMXBioPharmX Corporation
      11/21/20188:35AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      11/16/20186:00AMPR Newswire (US)BioPharmX Announces NYSE American Acceptance of Plan To Regain Listing ComplianceAMEX:BPMXBioPharmX Corporation
      11/02/20183:28PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
      11/02/20189:01AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      10/31/20186:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
      10/31/20184:13PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      10/22/20186:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
      10/12/20186:20PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
      10/11/20184:39PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      10/11/20184:30PMPR Newswire (US)BioPharmX Initiates Phase 2b Trial of BPX-04 for RosaceaAMEX:BPMXBioPharmX Corporation
      09/28/20189:17AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      09/28/20189:15AMPR Newswire (US)BioPharmX Receives Notice of Noncompliance from NYSE AmericanAMEX:BPMXBioPharmX Corporation
      09/20/20184:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
      09/13/20185:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
      09/13/20185:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
      09/13/20188:02AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      09/12/20185:30PMPR Newswire (US)BioPharmX Corporation Announces David S. Tierney, M.D. Joined the Company as Chief Executive OfficerAMEX:BPMXBioPharmX Corporation
      09/11/20187:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
      09/10/20184:08PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BPMXBioPharmX Corporation
      09/10/20184:06PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
      08/30/20184:19PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      08/30/20184:15PMPR Newswire (US)BioPharmX Reports Second Quarter 2019 Financial ResultsAMEX:BPMXBioPharmX Corporation
      08/17/20184:20PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
       Showing the most relevant articles for your search:AMEX:BPMX